Passkey Therapeutics
MA - CambridgeBiotechnology
Focus: Passkey Therapeutics is a Cambridge-based specialty biotech with a portfolio of legacy and generic pharmaceutical assets spanning immunology, oncology, respiratory, neurology, and hematology. The company operates primarily as a generics and branded generic manufacturer with minimal active pipeline development.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Passkey Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Passkey Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
1 imminent
ZONTIVITY
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
Glucocorticoid anti-inflammatory; drives 84% of company revenue and represents core cash engine but faces post-LOE generic erosion.
Help build intelligence for Passkey Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.